📍 MC3 Main Campus Convention Center, Allschwil (Basel)
🕔 October 23, 2025 | 17:25–18:00 CEST
💬 Panel: Beyond the Needle – Building the Future of Intratumoral Oncology
Today, Robert Aleksandrowicz, CEO of Cellis, steps in for Prof. Magdalena Król at Johnson & Johnson Innovation’s INTO event in Basel, joining an exceptional lineup of scientists and biotech leaders who are redefining how cancer is treated — from the inside out.
He will share Cellis’ perspective on how macrophage-based cell therapies can bridge local and systemic approaches, activating the immune system precisely where disease begins.
The “Beyond the Needle” discussion will spotlight the most forward-looking directions in oncology — intratumoral delivery, immune modulation, and technologies that make precision intervention a clinical reality. Events like this remind us how shared curiosity and collaboration drive the breakthroughs patients are waiting for.
We’re honoured to contribute to this dialogue among innovators shaping the next generation of cancer treatment.
